Navigation Links
Data on VELCADE(R) (Bortezomib) for Injection Based Therapies to be Presented at the International Myeloma Workshop
Date:2/23/2009

a
  • Abstract #247 Oral presentation session: Friday, February 27, 1:45 pm ET
  • Relapsed Multiple Myeloma

    Additional data will be presented on studies of VELCADE based therapies for patients with relapsed MM, including two presentations examining VELCADE in combination with novel agents:

    • Phase I study of elotuzumab (HuLuc63) in combination with bortezomib in relapsed multiple myeloma
      • Lead investigator: Andrzej Jakubowiak, M.D., Ph.D., Associate Professor, Department of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
      • Abstract #264 Oral presentation session: Friday, February 27, 1:30 pm ET

    • Panobinostat & bortezomib phase I trial in multiple myeloma
      • Lead investigator: Orhan Sezer, M.D., Department of Hematology and Oncology, Charite - Universitaetmedizin, Berlin
      • Abstract #337 Oral presentation session: Friday, February 27, 1:45 pm ET

    About Multiple Myeloma

    Multiple myeloma is the second most common hematologic malignancy and although the disease is predominantly a cancer of the elderly (the median age of onset is 70 years), recent statistics indicate both increasing incidence and younger age of onset. In the U.S., more than 50,000 individuals have MM and 20,000 new cases are diagnosed each year. Worldwide there are approximately 74,000 new cases and over 45,000 deaths annually.

    About VELCADE

    VELCADE is co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Millennium is responsible for commercialization of VELC
    '/>"/>

    SOURCE Millennium: The Takeda Oncology Company
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine news :

    1. FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
    2. Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
    3. Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
    4. VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial
    5. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
    6. Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy
    7. FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
    8. Inexpensive and Illegal Buttock - Boosting Injections Not Pretty
    9. Radiofrequency treatment better than ethanol injection for small liver tumors
    10. Bedford Laboratories(TM) to Begin Shipping Irinotecan HCl Injection
    11. Cosmetic Injections A Worthwhile Investment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/4/2015)... ... ... Dating a real millionaire online can be more difficult. Millionairematchapp.com is a ... the worries from meeting partners. Recently, the site announced they're publishing of a ... have responded with excitement. , “There's quite a few millionaire dating apps online, ...
    (Date:7/4/2015)... ... July 04, 2015 , ... ... industry’s leading recognition of technical sales expertise from the North American Board of ... ProfessionalTM. NABCEP is the most highly respected and well established national certification organization ...
    (Date:7/3/2015)... Greenville, SC (PRWEB) , ... ... ... Society has announced the sessions and speaker lineup for its 2015 ... nursing, taking place August 6-8, 2015 at the Renaissance Orlando at SeaWorld ...
    (Date:7/3/2015)... ... July 03, 2015 , ... ... providers, has been retained to lead a national chief nursing officer recruitment ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
    (Date:7/3/2015)... , ... July 03, 2015 , ... Jennifer Renee Hanes, ... Choice Emergency Room , the largest network of independent freestanding emergency rooms in the ... medical director of our Sienna Plantation facility,” said Executive Medical Director of First Choice ...
    Breaking Medicine News(10 mins):Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
    ... officials add hot peppers and cilantro as suspect foods, ... -- The number of people sickened in the ongoing ... types of tomatoes remain the suspected cause, U.S. health ... potential suspects as well. , "We continue to ...
    ... Peake: Provide Counseling for All Combat Veterans, WASHINGTON, ... other assistance in 39 additional,communities across the country where ... by fall 2009., "Community-based Vet Centers -- already ... VA,s mental health program," said Dr. James B. Peake,Secretary ...
    ... People are more likely to be,active in the summertime ... -- than at any other time of the year. ... at their peak. Natural Solutions: Vibrant,Health Balanced Living magazine ... just in time for the dog days ahead. The ...
    ... years of publishing groundbreaking research, the June issue of ... pivotal research and significant discoveries in the field of ... without charge from HFES., For over half a century, ... safety and efficiency of systems, environments, tools, and products. ...
    ... Calif. Children,s Hospital Oakland,s research institute is ranked ... National Institutes of Health to children,s hospitals. In 2007, ... awards from the NIH. This feat was accomplished with ... institute,s grants second in the nation. , ...
    ... inspire better performance by pressuring their teams. Now, proteomics ... their analyses. In a simple solution to a time-consuming ... in their protocol squeezes four hours of waiting into ... see how well it worked," said biochemist Daniel Lopez-Ferrer, ...
    Cached Medicine News:Health News:Salmonella Illnesses Now Largest Foodborne Outbreak in U.S. History 2Health News:Salmonella Illnesses Now Largest Foodborne Outbreak in U.S. History 3Health News:VA Vet Centers Coming to 39 Communities 2Health News:Stay Safe This Summer With Chemical-Free Sunscreen and DEET-Free Bug Repellent, Says Natural Solutions Magazine 2Health News:Human Factors Journal celebrates 50 years 2Health News:Pressured proteins: A little pressure in proteomics squeezes 4-hour step into a minute 2Health News:Pressured proteins: A little pressure in proteomics squeezes 4-hour step into a minute 3
    (Date:7/2/2015)... 2015 ResMed Inc. (NYSE: RMD ) today ... year ended June 30, 2015 results on Thursday, July 30, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
    (Date:7/2/2015)... Roche,s Bloodhound technology is on the ... hematology testing, according to Kalorama Information.  The healthcare ... its Bloodhound digital cell imaging technology –as newly ... hematology analyzer – is notable as a play ... leader CellaVision, but also compete more broadly in ...
    (Date:7/2/2015)... 2015  The Green Exchange, Inc., the developer,s of ... compliant mobile app that connects cannabis growers directly to ... announced today that their service provides the fastest delivery ... more than half a dozen other delivery apps that ... is unique in that it connects growers directly ...
    Breaking Medicine Technology:ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2
    ... SAN DIEGO , Feb. 16 PatientSafe Solutions, ... safety, today announced the executive management team tasked with executing ... patient safety in healthcare.  James M. Sweeney, Chairman and Chief ... eight successful healthcare product and service companies including Caremark, Bridge ...
    ... , CLEVELAND , Feb. 16 ... earned a NorTech Innovation Award for its advancements in radiation ... for its unique combination of medical imaging and radiotherapy, which ... therapy is used to treat nearly two-thirds of today,s cancer ...
    Cached Medicine Technology:PatientSafe Solutions, Inc. Announces Management Team 2PatientSafe Solutions, Inc. Announces Management Team 3ViewRay Wins NorTech Innovation Award 2
    ... and Response catheters comprise the world's ... for electrophysiology procedures. Their advanced catheter ... superior torque response with a soft, ... and French sizes, Supreme and Response ...
    Lumenis 1000 Integrated Slit Lamp Fully-integrated biomicroscope slit lamp laser delivery system, complete with built-in LaserLink, parallel optics, magnification changer, micromanipulator and multi...
    ... Adding the S-Link LaserLink to ... Selecta Duo, a versatile Nd:YAG ... laser that extends treatment capabilities ... anterior segment and posterior pole ...
    The ACP 215 is the automated closed system cell processor with integrated process control....
    Medicine Products: